Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders

This publication has 20 references indexed in Scilit:

• Heat Treatment Improves Glucose Tolerance and Prevents Skeletal Muscle Insulin Resistance in Rats Fed a High-Fat Diet
  Diabetes, 2009
• Improvement of Insulin Sensitivity by a Novel Drug, BGP-15, in Insulin-resistant Patients: A Proof of Concept Randomized Double-blind Clinical Trial
  Hormone and Metabolic Research, 2009
• HSP72 protects against obesity-induced insulin resistance
  Proceedings of the National Academy of Sciences, 2008
• Antipsychotic drug-induced weight gain mediated by histamine H₁receptor-linked activation of hypothalamic AMP-kinase
  Proceedings of the National Academy of Sciences, 2007
• Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects
  Neuropsychopharmacology, 2006
• Atypical Antipsychotics and a Src Kinase Inhibitor (PP1) Prevent Cortical Injury Produced by the Psychomimetic, Noncompetitive NMDA Receptor Antagonist MK-801
  Neuropsychopharmacology, 2005
• Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
  Obesity Research, 2004
• A central role for JNK in obesity and insulin resistance
  Nature, 2002
• Decreased Expression of Heat Shock Protein 72 In Skeletal Muscle of Patients With Type 2 Diabetes Correlates With Insulin Resistance
  Diabetes, 2002
• Association of Olanzapine-Induced Weight Gain With an Increase in Body Fat
  American Journal of Psychiatry, 2001